Hope in a Dose: CGT Podcast | Ep. 1 | What Makes CGT Trials Different?

Host: Louise Kearney, Head of Cell and Gene Therapy, Strategy and Delivery at FortreaParticipant: Darby Thomas, Senior Scientific Director for Cell and Gene Therapies, Fortrea Description: In this first episode, we're discussing why we should think differently about cell and gene therapy, clinical trials, and the kinds of challenges to conventional trial design, and which means that we have to think about different operation models.